A NEW APPROACH TO THE DESIGN OF SIGMA-2-SELECTIVE LIGANDS - SYNTHESIS AND EVALUATION OF N-[2-(3,4-DICHLOROPHENYL)ETHYL]-N-METHYL-2(1-PYRROLIDINYL)ETHYLAMINE-RELATED POLYAMINES AT SIGMA-1 AND SIGMA-2 RECEPTOR SUBTYPES

被引:21
作者
DECOSTA, BR
HE, XS
DOMINGUEZ, C
CUTTS, J
WILLIAMS, W
BOWEN, WD
机构
[1] Laboratory of Medicinal Chemistry, National Institutes of Diabetes and Digestive and Kidney Diseases, National Institutes of Health, Maryland 20892, Building 8, Room B1-23, 9000 Rockville Pike, Bethesda
[2] DuPont Merck Pharmaceutical Co., Experimental Station, Cardiovascular Diseases Research, Wilmington, DE 19880-0402.
关键词
D O I
10.1021/jm00028a016
中图分类号
R914 [药物化学];
学科分类号
100701 ;
摘要
A series of polyamines based on the high affinity sigma receptor ligand N-[2-(3,4-dichlorophenyl)ethyl]-N-methyl-2-(1-pyrrolidinyl)ethylamine (3) were developed and evaluated for their binding characteristics at sigma-1 and sigma-2 receptor subtypes. The data indicated that a considerable degree of structural variation is possible while still retaining nanomolar affinity at a receptors; As the structure of the polyamines was varied, their binding at sigma-1 and sigma-2 subtypes showed quite different and in some cases opposite trends, supporting the belief that these are pharmacologically distinct entities. Polyamines containing two nitrogen atoms showed optimal binding at both sigma-1 and sigma-2 receptor subtypes. Although additional nitrogen atoms resulted in decreased affinity at sigma-1 and sigma-2 subtypes, an increase in selectivity for sigma-2 subtypes was evident; the parent 3 showed greater selectivity for sigma-1 subtypes. Internitrogen spacings had a large effect on binding affinity and subtype selectivity. For example, the difference between N-[3-(1-pyrrolidinyl)propyl]-N'-(3,4-dichlorobenzyl)-N,N'-dimethylethylenediamine (8) [K-i = 29.9 nM at sigma-1 receptor and 18.3 nM at alpha-2 receptor] to N-[3-(1-pyrrolidinyl)propyl]-N'-(3,4-dichlorobenzyl)-N/N'-dimethylethylenedi- amine (10) [K-i = 1.49 nM at sigma-1 receptor and 12.1 nM at sigma-2 receptor] illustrates the importance of internitrogen spacing. Triamines 11 and 13 [K-i(sigma-2)/K-i(sigma-1) = 0.19 and 0.10, respectively] containing the N-N-N-Ar spacings 3-3-2 and 4-4-2, proved to be the most sigma-2 subtype selective of the 15 polyamines examined in this study. The N-N-N spacings appear to be an important factor in their sigma-2 subtype selectivity. These compounds will serve as templates in the design of still further sigma-2 subtype selective ligands. The pyrrolidine ring (present in most of the polyamines tested in this series) proved to be an important recognition site for a receptor binding activity. Furthermore, alkyl substitution also appears to be important since the stripped down polyamines N-[2-(3,4-dichlorophenyl)ethyl]ethylenediamine (15) and N-1-[2-(3,4-dichlorophenyl)ethyl] diethylenetriamine (16) exhibited relatively low binding affinity.
引用
收藏
页码:314 / 321
页数:8
相关论文
共 43 条
[31]  
Snyder S H, 1989, J Neuropsychiatry Clin Neurosci, V1, P7
[32]   SYNTHESIS AND EVALUATION OF NOVEL SPERMIDINE DERIVATIVES AS TARGETED CANCER CHEMOTHERAPEUTIC-AGENTS [J].
STARK, PA ;
THRALL, BD ;
MEADOWS, GG ;
ABDELMONEM, MM .
JOURNAL OF MEDICINAL CHEMISTRY, 1992, 35 (23) :4264-4269
[33]   STEROID BINDING AT SIGMA-RECEPTORS SUGGESTS A LINK BETWEEN ENDOCRINE, NERVOUS, AND IMMUNE-SYSTEMS [J].
SU, TP ;
LONDON, ED ;
JAFFE, JH .
SCIENCE, 1988, 240 (4849) :219-221
[34]   POTENTIAL ANTIPSYCHOTIC BMY-14802 SELECTIVELY BINDS TO SIGMA-SITES [J].
TAYLOR, DP ;
DEKLEVA, J .
DRUG DEVELOPMENT RESEARCH, 1987, 11 (01) :65-70
[35]   CHOLESTEROL LOWERING BILE-ACID BINDING-AGENTS - NOVEL LIPOPHILIC POLYAMINES [J].
THOMAS, EW ;
CUDAHY, MM ;
SPILMAN, CH ;
DINH, DM ;
WATKINS, TL ;
VIDMAR, TJ .
JOURNAL OF MEDICINAL CHEMISTRY, 1992, 35 (07) :1233-1245
[36]  
VILNER BJ, 1992, MULTIPLE SIGMA PCP R, P341
[37]  
WALKER JM, 1990, PHARMACOL REV, V42, P355
[38]   EVIDENCE FOR A ROLE OF HALOPERIDOL-SENSITIVE SIGMA-OPIATE RECEPTORS IN THE MOTOR EFFECTS OF ANTIPSYCHOTIC-DRUGS [J].
WALKER, JM ;
MATSUMOTO, RR ;
BOWEN, WD ;
GANS, DL ;
JONES, KD ;
WALKER, FO .
NEUROLOGY, 1988, 38 (06) :961-965
[39]   A COMPARISON OF (-)-DEOXYBENZOMORPHANS DEVOID OF OPIATE ACTIVITY WITH THEIR DEXTROROTATORY PHENOLIC COUNTERPARTS SUGGESTS ROLE OF SIGMA-2 RECEPTORS IN MOTOR FUNCTION [J].
WALKER, JM ;
BOWEN, WD ;
PATRICK, SL ;
WILLIAMS, WE ;
MASCARELLA, SW ;
BAI, X ;
CARROLL, FI .
EUROPEAN JOURNAL OF PHARMACOLOGY, 1993, 231 (01) :61-68
[40]  
WILLIAMS K, 1989, MOL PHARMACOL, V36, P575